baber/WOPTO huggingface dataset:
Patent CA-2744542-A1 (CA)
Inventor: TANAKA DAMIEN
IPC: A61L2/07
Filed: 2009-11-24
Abstract: A containerized medical waste treatment system for sterilizing and processing waste. The system includes an elongate, substantially enclosed container-like structure with an access door on at least one lateral side to accommodate the entry of moveable carts containing medical waste. The system further includes an autoclave for sterilizing medical waste, a shredder for processing the load after sterilization, a tipper for transferring the waste held in carts into the shredder, and a moveable roof panel for providing clearance for a cart that has been elevated by the tipper. At least one conveyor belt for receiving and directing sterilized. shredded waste into a previously positioned waste container is included. The system can perform an autoclave sterilization method which includes relatively short evacuation and heating cycles to remove air pockets within the mass of the load to reduce autoclave treatment times.
Patent CA-2745893-A1 (CA)
Inventor: KARNEZIS IOANNIS
IPC: A61B17/70
Filed: 2009-12-08
Abstract: The present invention relates generally to a surgical device for the correction of deformities of the spinal column and finds particular, although not exclusive, utility in devices which are surgically implantable. Presently known implantable surgical devices are unable to provide for the progressive correction of spinal deformities assisted by active movements of the human body without fusion of the involved part of the spinal column. The present surgical device comprises a spinal column straightening means for permitting the relative rotation of two substantially adjacent vertebrae about a common axis substantially only in opposite rotational directions.
Patent CA-2750862-A1 (CA)
Inventor: LONG JEFFREY KEITH
IPC: C07D409/04
Filed: 2010-03-03
Abstract: Disclosed are compounds of Formula (1), including all geometric and stereoisomers, JV-oxides, and salts thereof, wherein Q1 is a phenyl ring, naphthalenyl ring system, a 5- to 6-membered fully unsaturated heterocyclic ring or an 8- to 10-membered heteroaromatic bicyclic ring system, each as described with optional substituents as defined in the disclosure; Q2 is a phenyl ring, a naphthalenyl ring system, a 5- to 6-membered saturated, partially unsaturated or fully unsaturated heterocyclic ring, or an 8- to 10-membered heteroaromatic bicyclic ring system, each as described with optional substituents as defined in the disclosure;  X is O, S(O)m, NR4, CR5R16 C(O) or C(=S); and R1, R1a, R2, R4, R15 R16 and m are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula (1) and methods for controlling plant disease caused by a fungal pathogen comprising applying an effective amount of a compound or a composition of the invention. Also disclosed are compounds of Formula (2), including all geometric and stereoisomers, and salts thereof, wherein X  is NH; and Q1, Q2 and R2 are as defined for Formula (1); which are useful as intermediates for preparing compounds of Formula (1).
Patent CA-2752664-A1 (CA)
Title: Composition a base d'europium, d'oxyde d'yttrium ou de gadolinium, de type coeur/coquille, luminophore comprenant cette composition et procedes de preparation
Inventor: BUISSETTE VALERIE
IPC: C09K11/78
Filed: 2010-03-25
Abstract: L'invention concerne une composition, ainsi qu'un luminophore à base de cette composition, qui comprend un cur minéral et une coquille à base d'europium et d'un oxyde d'ytthum ou de gadolinium et recouvrant de façon homogène le cur minéral sur une épaisseur égale ou supérieure à 300 nm. La composition est obtenue en formant une suspension comprenant le cur minéral et dont le pH est compris entre 8 et 11; en ajoutant à la suspension une solution contenant un sel d'europium et un sel d'yttrium ou de gadolinium et en maintenant le pH du milieu réactionnel à une valeur constante; en séparant le solide formé et en le calcinant à une température d'au plus 1000°C.
Patent CA-2752819-A1 (CA)
Inventor: SHIBA SHINGO
IPC: H04L12/44
Filed: 2009-11-02
Abstract: An object of the present invention is to improve the accuracy of bandwidth control by an optical line terminal 1 by preventing an optical network unit 2 from performing upstream transmission of an amount of data that is not expected by the optical line terminal 1. The optical network unit 2 of the present invention is an optical network unit in a PON system, which is capable of performing bidirectional optical communication with the optical line terminal 1 through a passive light-splitting node 6, and which performs upstream transmission of a FEC frame including a variable length frame to the optical line terminal 1. The optical network unit 2 includes a grant processing unit 207 that determines whether an amount of allocation specified in a grant G1 which is a report request is one unit amount of data (one FCW) of the FEC frame; and a frame transmitting unit 206 that transmits only a report R to the optical line terminal 1 if a result of the determination is affirmative.
Patent CA-2753091-A1 (CA)
Title: The timony dt1947 rigid steel ug bulkhead assembly
Inventor: TIMONY DAVID HILAIRE
IPC: E21F17/103
Filed: 2011-09-19
Abstract: The invention is a steel frame apparatus installed in a safe manner to provide support for the construction of a concrete (Shotcrete) bulkhead. In underground mines, bulkheads / barricades are used to contain solid material, liquids or as ventilation stops. The bulkhead sites are in dangerous areas and the installation of the bulkheads must follow the Mining Act. The Timony DT1947 onsite assembled apparatus meets the Mining Act requirements and the engineering containment specifications for use as a bulkhead and not only a barricade. The main steel components are an anchored top support beams, a locked wall frame matrix and an adjustable turnbuckle brace.
Patent CA-2753838-A1 (CA)
Inventor: CATELLI ROBERTO
IPC: A23L2/02
Filed: 2010-01-28
Abstract: The process for producing fruit juices comprises a stage of obtaining a fruit puree with an ultra-rapid extraction-deactivation process in an anaerobic environment, performed by means of immediate refining and a contemporaneous heating of a fruit triturate in an anaerobic environment, and a subsequent stage of pressing or centrifugation of the puree, with the aim of obtaining the fruit juice, which may be preceded by a stage of sterilisation-cooling and of temporary storing of the puree.
Patent CA-2754379-A1 (CA)
Inventor: LE KEVIN
IPC: H05B44/00
Filed: 2011-10-07
Abstract: An apparatus including a motor assembly having a motor. A jet assembly coupled to the motor assembly having an inlet and outlet aperture. An impeller configured to rotate causing a first fluid to flow into the inlet aperture and out the outlet aperture. A fluid guider that includes at least one wall member defining a first channel configured to guide the first fluid from the inlet aperture into the cavity.  Additionally, the fluid guider includes at least one post defining a second channel extending through the post. The second channel configured to guide the first fluid from the cavity towards the outlet aperture and output the first fluid at an oblique angle with respect to a longitudinal axis of the post. A second fluid channel member configured to provide a second fluid out the outlet aperture. A light source configured to illuminate the first fluid.
Patent CA-2754481-A1 (CA)
Inventor: GROVER SIMON RODERICK
IPC: A61B17/22
Filed: 2011-10-03
Abstract: A specimen retrieval apparatus includes a housing having an elongated tubular member extending distally therefrom. The elongated tubular member defines a longitudinal axis. An end effector assembly is coupled to a distal end of the elongated tubular member.  The end effector assembly is configured to retain a specimen retrieval bag thereon. An articulation mechanism is operatively coupled to the elongated tubular member and the end effector assembly. The articulation mechanism is configured for selectively articulating the end effector assembly with respect to the longitudinal axis of the elongated tubular member.
Patent CA-2755618-A1 (CA)
Inventor: ARCHDALL TANYA
IPC: F16G11/12
Filed: 2011-10-20
Abstract: A clip for a strap adjustment slider of the type fastened to one end of a strap, with a loop of the strap passing through the slider, the clip having a panel of thermoplastic material defining length and breadth, and having a breadth appropriate to pass through the slider, a tongue on at least one end of the panel, formations on the panel for gripping the slider.
Patent CA-2759139-A1 (CA)
Inventor: DEKKER PIETER
IPC: E21B19/16
Filed: 2011-11-16
Abstract: The present disclosure relates to the field of drilling equipment for the discovery and production of hydrocarbons from the earth. In particular, this disclosure relates to a torque reaction device for coupling a pipe running tool to a top drive assembly on a drilling rig. In one embodiment, a system for coupling a pipe segment to a pipe string includes a top drive assembly, a pipe running tool, and a torque reaction device. The top drive assembly includes an output shaft and a link extending from the top drive. The top drive is operative to rotate the output shaft with respect to the link. The pipe running tool is coupled to the output shaft and is engageable with a pipe segment to transmit torque from the output shaft to the pipe segment. The torque reaction device couples the pipe running tool to the link. TP/tp
Patent CA-2759424-A1 (CA)
Title: Collagen peptide composition having good ability to enter the blood and food or beverage containing the same
Inventor: OHARA HIROKI
IPC: C07K4/12
Filed: 2010-04-13
Abstract: The purpose of the present invention is to find out collagen peptides effective for transferring di- or tripeptides, which serve as the active components of collagen, into the blood to thereby reduce the required intake thereof. Disclosed is a collagen peptide composition obtained by digesting collagen or gelatin with protease, characterized in that: (a) the ratio of hydroxyproline in the amino acid residues at the second position from the N-terminus of the peptides contained in the composition is 2 to 20 mol% inclusive, and the ratio of glycine in the amino acid residues at the third position from the N-terminus thereof is 20 to 50 mol% inclusive; and (b) the average molecular weight of the composition is 500 to 2000 inclusive.
Patent CA-2761652-A1 (CA)
Title: Ablation therapeutique de bourgeon dentaire
Inventor: COLBY LEIGH E
IPC: A61C3/02
Filed: 2010-05-10
Abstract: L'invention porte sur une procédure d'ablation. La procédure d'ablation peut être appliquée à des bourgeons dentaires (120) et conduit à une agénésie dentaire. La procédure d'ablation peut être appliquée à des lésions ou à des tumeurs. L'invention porte sur un système d'ablation de bourgeon dentaire pour utilisation dans une procédure d'ablation de bourgeon dentaire conduisant à une agénésie dentaire. L'invention porte sur un procédé de balayage en volume à la fois des tissus durs et des tissus mous d'un patient. L'invention porte sur un procédé de réalisation ou de fabrication d'un stent chirurgical personnalisé (110). L'invention porte sur un stent chirurgical personnalisé (110) pour utilisation dans une procédure d'ablation de bourgeon dentaire qui conduit à une agénésie dentaire, le stent chirurgical personnalisé (110) pour utilisation avec un embout de sonde d'ablation (108) comportant un centre d'ablation (130a).
Patent CA-2764022-A1 (CA)
Title: Combinations of pneumococcal rrgb clades
Inventor: MASIGNANI VEGA
IPC: A61K39/09
Filed: 2010-06-01
Abstract: Pneumococcal pilus subunit RrgB has at least three clades. Serum raised against a given clade is active against pneumococci which express that RrgB clade, but is not active against strains which express one of the other two clades i.e. there is intra-clade cross-protection, but not inter-clade cross-protection. Thus an immunogenic composition can include at least two different clades of RrgB to improve strain coverage against pilus-containing pneumococci. These multiple clades may be present in the immunogenic composition as separate polypeptides or may be fused as a single polypeptide chain.
Patent CA-2768923-A1 (CA)
Title: System and/or method for reducing ambiguities in received sps signals
Inventor: PON RAYMAN WAI
IPC: G01S19/46
Filed: 2007-08-23
Abstract: Systems, apparatuses, and/or methods for resolving ambiguities associated with signals received from space vehicles (SVs) in a satellite navigation system. For example, certain methods include receiving a first SV signal from a first satellite positioning system (SPS), and reducing a bit edge ambiguity of a data signal modulating a second SV signal received from a second SPS based, at least in part, on information in the received first SV signal.
Patent CA-2773321-A1 (CA)
Title: Method and apparatus for automated cell transfer therapy and hair transplantation
Inventor: WU ALLAN Y
IPC: A61F2/10
Filed: 2010-09-14
Abstract: Methods and apparatuses that selectively capture therapeutic cells associated with hair growth or development and their delivery to regions of hair loss. Cell capture and delivery is accomplished in part through the use of antibodies having binding sites specific to cell surface moieties characteristic of the therapeutic cells and having magnetic or paramagnetic features, which facilitates their immobilization to magnetizable rods that can be used to pierce the skin of the subject being treated for hair loss and the subsequent release of therapeutic cells to targeted sites beneath the epidermis.
Patent CA-2777619-A1 (CA)
Inventor: PAULSEN JENS
IPC: H01M4/505
Filed: 2010-10-19
Abstract: A lithium transition metal oxide powder for use in a rechargeable battery is disclosed, where the surface of the primary particles of said powder is coated with a LiF layer, where this layer consists of a reaction product of a fluorine-containing polymer and the primary particle surface. The lithium of the LiF originates from the primary particles surface. Examples of the fluorine-containing polymer are either one of PVDF, PVDF-HFP or PTFE. Examples of the lithium transition metal oxide are either one of - LiCodMeO2, wherein M is either one of both of Mg and Ti, with e<0.02 and d+e=1; - Li1+aM'1 -aO2±b M1 k Sm with -0.03<a<0.06, b<0.02, M' being a transition metal compound, consisting of at least 95% of either one or more elements of the group Ni, Mn, Co and Ti; M1 consisting of either one or more elements of the group Ca, Sr, Y, La, Ce and Zr, with 0=k=0.1 in wt%; and 0<m<0.6, m being expressed in mol%; and - Lia NixCOy M"z O2±e Af, with 0.9<a'<1.1, 0.5=x=0.9, 0<y=0.4, 0<z=0.35, e<0.02, 0=f=0.05 and 0.9 <(x+y+z+f) < 1.1; M" consisting of either one or more elements from the group Al, Mg, and Ti; A consisting of either one or both of S and C.
Patent CA-2777895-A1 (CA)
Title: Flow control device for a smoking article
Inventor: LE ROUX GERHARD MALAN
IPC: A24D3/04
Filed: 2010-10-15
Abstract: A smoking article such as a filter cigarette includes a rotary flow control device (2) in its filter assembly that comprises first, second and third body portions (3, 4, 5). The first body portion (1) contains a plug (6) of filter material and is attached to a tobacco rod (1). The second portion (4) contains different smoke flavourants in different sectors (18), which can be aligned by manual rotation individually with a smoke flow passageway (13, 35) to impart different flavours to the smoke that passes to the mouth of the consumer. The second body portion (4) is rotated through the agency of the third body portion (5). First and second ratchet mechanisms (14,19; 20, 24) are disposed between the second body portion (4) and the first and third body portions respectively to allow assured rotation of the second portion to select individual flavourants for the smoke passing to the consumer.
Patent CA-2778928-A1 (CA)
Title: Precipitated magnesium carbonate
Inventor: POHL MICHAEL
IPC: C09C1/02
Filed: 2010-11-02
Abstract: The present invention relates to a process for preparing hydromagnesite in an aqueous environment. The invention further relates to such hydromagnesite having a specific platy-like morphology in combination with a specific average particle size and to their use as minerals, fillers and pigments in the paper, paint, rubber and plastics industries and to the use as flame-retardant.
Patent CA-2778992-A1 (CA)
Title: Method and system for displaying variable shaped products on a computer display
Inventor: TIRRELLA TERENCE M
IPC: G06F17/30
Filed: 2009-10-28
Abstract: A computerized system, method, and computer-readable media implementing a method for defining a variable shaped document for web viewing is presented. Markup language descriptions are defined for outlines defining a shape of an item to be produced, and for content to be displayed on the item within the boundaries of the outlines. Markup language rules area defined that prevent display of content in areas on a display screen outside the defined shape of the item to be produced.
Patent CA-2781522-A1 (CA)
Inventor: ABULJADAYEL ILHAM MOHAMMED SALEH SAEED
IPC: A61K35/545
Filed: 2009-10-19
Abstract: A method of treating various diseases, disorders, or conditions in patient using reprogrammed cells such as retrodifferentiated, transdifferentiated, or redifferentiated cells. The method comprises obtaining committed cells from the patient, retrodifferentiating the committed cells to obtain retrodifferentiated target cells, and administering the retrodifferentiated cells to the patient. In certain embodiments, the method comprises obtaining committed cells from the patient, transdifferentiating the committed cells to obtain transdifferentiated target cells, and administering the transdifferentiated target cells to the patient. The retrodifferentiated or transdifferentiated target cells repair or replenish tissue or cells in the patient.
Patent CA-2781650-A1 (CA)
Inventor: RODINGER TOMAS
IPC: G16B40/30
Filed: 2010-11-23
Abstract: A new density based clustering method for clustering data points in multidimensional space is described. Each point has a neighborhood consisting of all points that are within a preset cutoff radius or distance. Each point is assigned a density measure based on the number of points in its neighborhood. Any point that has a higher density than any of its neighboring points is the centre of a cluster and is assigned a unique cluster ID. Every other point follows a path through the graph of neighboring points such that density is increasing as fast as possible until a cluster center is reached. The algorithm's performance is demonstrated on a one-dimensional, two-dimensional, and 18-dimensional dataset.
Patent CA-2782173-A1 (CA)
Inventor: LEWIS ADAM
IPC: A61H19/00
Filed: 2010-11-30
Abstract: The invention relates to a simple and easy to use stimulatory device which allows the user to apply vibrations to the frenulum, whilst being an essentially hands-free device, so that the user does not have to manually hold or manipulate the device during use. In an embodiment, the device allows the user to control the amplitude and frequency of the vibrations applied to the frenulum.
Patent CA-2782770-A1 (CA)
Inventor: HAUSER CARL J
IPC: C12Q1/68
Filed: 2010-12-03
Abstract: The present invention provides methods for predicting the likelihood that a subject will develop a sterile inflammation, identifying a subject that has increased propensity to later develop a sterile inflammation, determining whether a subject with tissue damage should be administered an antimicrobial agent or a reduced dosage of an antimicrobial agent, and treating a subject with tissue damage that require the steps of: measuring the amount of microbial nucleic acid and peptide in a sample from the subject, measuring the amount of mitochondrial nucleic acid or peptide in the sample, and comparing the amount of microbial nucleic acid or peptide to the amount of mitochondrial nucleic acid or peptide. In the provided methods, an increased ratio of the amount of mitochondrial nucleic acid or peptide to the amount of microbial nucleic acid or peptide indicates a subject that has an increased likelihood of later developing a sterile inflammation, identifies a subject that has an increased propensity to later develop a sterile inflammation, identifies a subject that should not be administered an antimicrobial agent or administered a reduced dosage of an antimicrobial agent, or identifies a subject that should be administered one or more anti-inflammatory agents and not administering, or administering at a reduced dosage, an antimicrobial agent. Kits containing one or more oligonucleotide primers for amplification of microbial nucleic acid and one or more oligonucleotide primers for amplification of a mitochondrial nucleic acid, and kits containing one or more antibodies that specifically bind to microbial peptides and one or more antibodies that specifically bind to mitochondrial peptides are also provided.
Patent CA-2783586-A1 (CA)
Inventor: EASTHAM GRAHAM RONALD
IPC: C07C45/49
Filed: 2010-12-15
Abstract: A method of increasing the TON of a catalyst system for the monocarbonylation of ethylenically unsaturated compounds using carbon monoxide in the presence of a co- reactant, other than water or a source thereof, having a mobile hydrogen atom is described. The catalyst system is obtainable by combining: (a) a metal of Group (8, 9) or (10) or a suitable compound thereof; (b) a ligand of general formula (I) wherein the groups X3 and X4 independently represent univalent radicals of up to 30 atoms or X3 and X4 together form a bivalent radical of up to 40 atoms and X5 has up to 400 atoms; Q1 represents phosphorus, arsenic or antimony; and c) optionally, a source of anions. The method includes the step of adding water or a source thereof to the catalyst system. The method is preferably carried out in the presence of an electropositive metal.
Patent CA-2790143-A1 (CA)
Title: Solid composition for the oral administration of dyes and diagnostic use thereof
Inventor: MORO LUIGI
IPC: A61K49/00
Filed: 2011-03-02
Abstract: Herein described are solid compositions for the oral administration of dyes, and diagnostic use thereof. Preferably, such diagnostic use is aimed at the diagnostic evaluation of the gastrointestinal tract.
Patent CA-2790326-A1 (CA)
Inventor: GILLIES GEORGE T
IPC: A61M5/00
Filed: 2010-12-21
Abstract: An access system and method for obtaining access to the interior vascular structures or other regions or collections of fluid or fluid-filled cavities inside the body. The system and method provides for injection of contrast agents (to confirm ideal position or condition), the passage of guide wires, and the eventual catheterization of the heart and other parts of the body via the pathway established through the puncture of a femoral artery. The system and method provides the ability to inject a contrast material and pass a guide wire through the same introducer device simultaneously (without necessarily moving it or removing any parts), with the device designed to prevent the backflow of the contrast material through the guide wire port during the contrast injection process The ideal location of access in the vein or artery can be seen by injecting contrast from a needle inside the structure and then using fluoroscopy.
Patent CA-2790743-A1 (CA)
Title: Buttress release from surgical stapler by knife pushing
Inventor: HODGKINSON GERALD
IPC: A61B17/285
Filed: 2012-09-24
Abstract: A surgical stapling apparatus including a releasable buttress material includes a cartridge assembly, an anvil assembly, a knife, and a buttress material. The cartridge assembly includes a plurality of staples and a tissue contacting surface defining staple retaining slots. The anvil assembly includes a tissue contacting surface defining staple pockets for forming staples expelled from the staple retaining slots of the cartridge assembly. The knife is disposed within a knife slot formed in the tissue contacting surface of the cartridge assembly. The buttress material includes at least one weld joining the buttress material to the tissue contacting surface of the cartridge assembly. The at least one weld is positioned across the knife slot.